Page last updated: 2024-12-07

cytidylyl-(3'-5')-cytidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cytidylyl-(3'-5')-cytidine, also known as CpC, is a dinucleotide composed of two cytosine nucleotides linked by a phosphodiester bond. It is a common component of DNA and RNA and is involved in various biological processes. CpC is known to be a substrate for DNA polymerases and is also involved in the regulation of gene expression. The synthesis of CpC can be achieved through enzymatic reactions using DNA or RNA polymerases. CpC is studied extensively because of its role in DNA replication, transcription, and other cellular processes. Its presence in DNA can influence the stability of the double helix and affect the binding of transcription factors. Research on CpC is aimed at understanding its role in gene regulation, DNA repair, and other cellular processes. Studies have shown that CpC methylation can alter gene expression and be associated with various diseases. Further research is being conducted to develop therapies targeting CpC methylation for the treatment of cancer and other diseases.'

Cross-References

ID SourceID
PubMed CID94237
MeSH IDM0064130

Synonyms (9)

Synonym
cytidylyl-(3'-->5')-cytidine
cytidine-3'-phosphate-5'-cytidine
nsc 91550
cytidylyl-(3'-5')-cytidine
nsc 131650
cytidylyl-(3'.5')-cytidine
einecs 219-802-9
DTXSID901311479
((2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl ((2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1(2h)-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl) hydrogen phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nucleobase-containing molecular entityAny compound that has a nucleobase as a part.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (25.00)18.7374
1990's4 (33.33)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.90 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]